Background. -Since the prospective payment system, health institutions have only specific payments for the emergency care in the emergency room. The direct urgent admissions in coronary care units for acute coronary syndrome (ACS) do not collect this complementary refund. For the patient's stay, hospital is remunerated with fixed national prices which are similar even in case of emergent or planed coronary revascularization when realized ; p = 0,001). This overcost was due especially to drugs and biological expenses. The hospitalization payments did not cover the overall expenses for 25% of the patients' stays (N = 64) among whom 39 have had emergent coronary stenting (30.7%, p = 0.04). Among the different GHM, the most important difference was observed in non-STEMI without complication with a negative receipts/costs ratio for 37.8% of the stay with coronary stenting in emergency.
Introduction
Since the introduction of activity-based funding in 2004 (T2A 1 ), public health establishments receive specific funding for medical or surgical emergencies carried out by the emergency services [1] . This funding is broken down into a financial budget that is connected to the volume of activity undertaken, and an annual set budget. The funding connected to the activity undertaken incorporates national prices that are applied to each hospital short-term stay in the emergency department of the hospital catchment area as well as a flat rate of 25 D (ATU) granted for each time a patient is admitted to the emergency department, to which are added rates for procedures carried out that fall under the French National Health Insurance Scheme (CCAM) and under the General Professional Procedure Nomenclature (NGAP). The flat-rate financing includes the annual emergency flat rate (FAU) which is to cover the fixed costs of the emergency department, especially personnel and facilities [2, 3] . However, direct emergency admissions to the nonemergency medical department do not give rise to specific additional funds. This applies mainly to the treatment of acute coronary syndromes (ACS) admitted in an emergency to the cardiac intensive care unit (UCIS) and immediate treatment for surgical catheterisation. For these admissions, the establishment receives a rate based on the diagnosis-related group (DRG), which is laid down at national level and to which are added daily intensive care and reanimation supplements. So, the rate allocated to each hospital stay does not differ depending on whether the patient's treatment is performed as an emergency or whether it is planned. The organisational consequences, however, of emergency treatment by the medical care services are not negligible. Nonscheduled medical procedures as a causal factor of cost discrepancies were mentioned in the IGAS report [4] . Based on activity data from the IT Medical Care Provision Programme (PMSI) and the cardiology department, the aim of this paper is to study the financial impact of nonscheduled treatment of ACS with the insertion of a coronary stent compared with scheduled treatment, and to examine variables to explain this, if supplementary costs are incurred, and the share allocated to each of them. After this analysis, a comparison was carried out between the observed expenses and the income received per hospital stay.
Methodology
Definitions of the scope of the study and identification of the population studied This is a retrospective study carried out using activity data for 2005 in our cardiology department. The study deals with hospital stays for the treatment of ACS requiring a coronary stent to be inserted. The stays that have been taken into account are those between 01 January 2005 and 31 December 2005. These stays have been differentiated according to the type of patient care, making a distinction between emergency and scheduled treatment. This concern is particularly felt in the cardiology department due to its regional catchment area.
Definition of an emergency
The definition of emergency treatment with catheterization and the insertion of an endoprosthesis applies to patients having suffered an ACS requiring the patient be transferred to coronarography in the UCIS upon admission. After a clinical and paraclinical assessment, the senior cardiologist on duty confirms the need to transfer the patient to coronarography immediately in order to ensure coronary revascularisation as quickly as possible. The type of patient that fits this criterion is patients suffering from an ACS with persistent ST segment elevation, possibly with haemodynamic complications (cardiogenic shock), or suffering from a recurring ACS without ST segment elevation, or patient who do not respond to normal medical treatment. Mechanical complications of the myocardial infarction that also require emergency coronarography care are excluded from this study, as are the cases leading to an indication for surgical intervention. Only patients that underwent ad hoc revascularisation with coronary stenting are covered in this paper.
Definition of DRG and clinical correspondence
For each stay with emergency treatment entailing the insertion of a coronary stent, matching was carried out during a stay where a coronary stent was inserted followed by a scheduled coronary exploration on the same time. The matching was based on patient variables (age, gender) and on the stay (case-mix group [CMG]) resulting from data compiled on the activity of the stay. The typing of these stays varies according to the main diagnosis recorded in the medical unit summary, any complications and morbidities associated with the main treatment, and medical treatment carried out, in this case revascularisation using a coronary stent. This information results in the patient being allocated to one of four DRG in accordance with version 10.10 of the typing algorithm: PMSI 05K05V ''vascular endoprostheses and myocardial infarction (MI) without complications and associated morbidities (CAM)'' and 05K05W ''vascular endoprostheses and MI with death and/or complications and/or associated morbidities''. These two groups correspond in practice to primary angioplasty cases or a transfer to the ''emergency'' group. The ''scheduled'' patients in these two DRG correspond to patients with ACS with raised ST segmentation hospitalised too late or transferred after successful thrombolysis in a nearby establishment. Coronary angioplasty with a stent is then carried out some time after admission. Both of the other two remaining groups, 05K06V ''vascular endoprostheses without MI without CAM'' and 05K06W ''vascular endoprostheses without MI with CAM'' correspond to coronary endoprostheses proposed without raised ST segmentation. Emergency corresponds to examination with stents carried out on patients ACS without refractory raised ST segmentation or accompanied by serious symptoms. The scheduled situations correspond to the same circumstances, but without raised ST segmentation, and that are not with high risk, such that a coronarography can be planned a certain time after admission.
Each case-mix group has been attributed to a DRG since 2004, and activity-based funding for medicine, surgery and obstetrics (MSO) has been applied since then. The DRG is a tariff that is calculated at national level and is common to all public health establishments; it is allocated to the establishment to look after this patient. The notion of emergency or scheduled treatment does not change the amount allocated for the treatment of each patient. The information recorded in the medical summary documents is systematically checked to ensure the quality of the matching. The coding of the main diagnoses and associated diagnoses has been reviewed for each file included based on information found in the medical file. No errors were found regarding the main diagnosis, associated diagnoses or the medical treatment recorded in the files selected for this study.
Compiling the variables
The variables compiled for the analysis came from three sources:
• medical activity data from the PMSI for ''patient ' 
Imputation of hospitalisation expenditure
The methodology used to break down hospitalisation expenditure is that laid down by the National Costs Study (ENC) [5] . Expenditure is divided up according to whether it is charged directly or indirectly to the hospital stay. If the information is known, the expenditure is allocated by stay. This is direct expenditure. If the information is not available to allocate the expenditure to a stay, the basis for cost allocation for this expenditure is chosen in accordance with the recommendations laid down in the analytical accounting methodology guide of the ENC study [5, 6] . The expenditure taken into account in this study is that of all the departments that took part in patient treatment. The expenditure of the medical-technical cardiology platform appears in the expenditure of the medical-technical platforms broken down according to the cost allocation base referred to as the relative cost index (ICR) used by the clinical services.
Personnel and clinical services expenditure
Personnel expenditure is divided into medical, paramedical personnel and other personnel. The cost of personnel is divided into medical units according to the allocation of funds declared by the health executive and the head of department. This expenditure identified by the medical unit has been broken down indirectly by stay. The cost allocation base of this expenditure is the day of hospitalisation.
Medication and medical device expenditure
Medication and medical device expenditure is allocated directly to the stay as soon as the information has been ascertained and is available, and more particularly for medication and MID that may significantly change the cost of the stay. This is the case of abxicimab (Reopro ® ), used mainly for urgent treatment of ACS, and coronary endoprostheses. Medication and medical device expenditure that has not been possible to attribute directly to the stay is broken down on a pro rata basis of expenditure already recorded.
Medical logistics expenditure
Medical logistics expenditure includes pharmaceutical expenditure (operating costs of the pharmacy, i.e. salary of the personnel allocated to this department, amortisation and maintenance of equipment specific to this activity, consumables), sterilisation, medical IT department (DIM), biomedical engineering as well as expenditure connected with vigilance (hemovigilance, pharmacovigilance, medical devices vigilance). This expenditure is itemised for each medical unit that incurs the expenditure. This expenditure is then broken down on a pro rata basis per days of hospitalisation.
Medical-technical services expenditure
Medical-technical services are services that perform procedures quoted in the form of a RCI (for surgery, exploratory procedures, anaesthesiology, radiology), of B and nonstandard B nomenclature (BHN) for laboratories, and sections the patient passed through (recovery room, incoming emergency ward). The expenditure of the medical-technical services is broken down on a pro rata basis per cost allocation base, and then procedures performed by the clinical services. All medical-technical procedures were allocated to one of the stays in this study.
Logistics and general management expenditure
This expenditure includes in particular expenditure on laundry, catering and administrative costs, admissions and patient management, maintenance, moving patients on a stretcher. The laundry and catering expenditure is allocated by the medical unit according to the level of consumption of each one. Other expenditure is broken down by the medical unit according to expenditure already recorded. This expenditure is then broken down for each stay on a pro rata basis in terms of the number of days of hospitalisation. Establishment expenditure has not been broken down by hospital stay.
Valuation of stays
Hospitalisation income linked to each stay is calculated in accordance with the tariffs and tariff regulations of 2006. This income includes the stay tariff or DRG to which is added if relevant: the valuation of the supplementary days accounted for beyond the upper limit of the DRG, supplements for reanimation and/or intensive care, renal dialysis sessions, income from MID paid over the hospitalisation tariff. The valuation figures are calculated at 100% of the activity-based rate.
Data analysis
The medical data were recorded in Excel 2000
® . The PMSI activity data come from the software Orbis ® (by Agfa). The data were analysed using StatView ® (SAS Institute, Berkeley, CA). The continuous variables (age, length of stay) are expressed as an average, with a confidence interval of 95%, and a distribution median of the length of the stay. The nominal variables (gender, entry method) are presented as gross data and frequency of distribution. The nonmatched t-test was used to analyse continuous variables. If the conditions were not met to use the t-test, the U-Mann and Whitney test was used to analyse the continuous variables. The 2 test was used to test for differences between category variables. The level of significance (p) was set at 0.05. A value of p under 0.05 was considered to be statistically significant.
Results
During 2005, 154 patients were admitted to the emergency department, with an ACS and who were fitted with a coronary stent, which comes to 5.7% of all patients (N = 2723) treated in the cardiology department in 2005 and 3.3% of stays (N = 4632) over this period. Eighty-seven (68.5%) of the medical procedures were carried out outside of working hours, of which 36 (28.3%) at the weekend and on national holidays and 51 (40.2%) during the night. Scheduled treatments represented 449 stays and patients in 2005, i.e. 16.5% of patients and 9.7% of stays in 2005. Matching between stays for emergency treatment and scheduled treatment was performed for 127 of the 154 stays (82.5%) for the three following variables: age, gender and case-mix group. In total, the study is based on 254 stays for coronary treatment requiring the insertion of a coronary stent. Table 1 shows the sociodemographical characteristics of the patients included. There is no statistically significant difference between the emergency cases and patients whose stay was scheduled for the matching variables (gender and age).
Sociodemographic characteristics of the patients (N = 254)

Characteristics of the stays (N = 254)
The case-mix group was a stay-matching variable, so there was no statistically significant difference in the distribution of these case-mix groups between patients admitted as an emergency and those admitted for scheduled treatment (p > 0.05) ( Table 1 ). The stays 05K05V (ACS with raised ST segmentation) and 05K06V (ACS without raised ST segmentation), without complications or associated comorbidity, account for a majority of those in the study (N = 184; 72.4%). The average length of the stay is 6.7 days [5.9; 7.4] CI95 . The median length of stay is 5 days. The average length of stay does not vary significantly according to whether the patient is an emergency or scheduled case (p > 0.05).
The average length of stay varies significantly according to case-mix group (p < 0.0001): 5.6 for the case-mix group 05K05V ''vascular endoprostheses and MI without associated complications and morbidities'' compared to 9.9 days of hospitalisation on average for the same case-mix group with associated complications and/or morbidities (05K05W). There is also a significant difference with regard to the average length of stay for coronary endoprosthesis implants without infarction: the average length of stay for patients without complications (05K06V) is 5.0 days compared with 10.8 days if a complication or a comorbidity is declared during the stay (05K06W).
Expenditure and income for stays (N = 254)
The total value observed for all stays included in the study is 1,758,597 D (Tables 2 and 3 The method of admission ''Transfer'' is defined as a patient admitted from another legal body for hospitalisation. The discharge method ''Transfer'' is defined as patient discharged to another legal body for hospitalisation. A ''Move'' is defined as a patient discharged to another medical unit within the same legal body. 
Discussion
The description of our population complies with the recommendations of guidelines on this topic; the majority of urgent cases were primary angioplasty procedures for ACS with raised ST segmentation and ACS without raised ST segmentation with comorbidities or complications [6, 7] .
This study attempted to evaluate the financial impact of nonscheduled treatment in the cardiology department, the highest number of cases in this discipline. We showed that there is an additional cost of 1600 D for emergency cases compared to that for scheduled cases. This additional cost stems from expenditure on the following items: medication, mainly for GP IIb/IIIa inhibitor drugs, and laboratory tests. Personnel expenditure does not appear to be significantly different between the two groups, but the value observed is close to the level of significance. This study would have greater impact if there were a larger number of stays included. The additional costs observed for scheduled treatment in the expenditure item of MID depend on the condition of the patients. The more stable the condition, the more coronary lesions can be treated through inserting Table 3 Summary table of several coronary stents during the same procedure. The difference observed between income and expenditure is on the whole positive for both, but it is two and half times higher for scheduled treatment. It is important to state that income does not cover the expenditure incurred in a third of nonscheduled cases. Applying the applications of learned societies on emergency angioplasty for ACS, in particular outside of normal working hours, involves a financial investment from the hospitals, as the costs incurred are only partially covered by the DRG funding and supplements. With the current remuneration method, scheduled coronary stent implants on the contrary bring in great financial benefits, particularly in the group of ACS without raised ST segmentation without complications. To this must be added, the organisational and financial impact of cancelling scheduled procedures. Emergency treatment of some patients, apart from the additional costs caused by this treatment, causes organisational difficulties for the clinical services that are forced to cancel procedures on patients that had already been planned. These cancelled procedures lengthen scheduled stays and indirectly bring about an increase in the cost of the stay. The financial impact of these cancellations has not been evaluated in our study.
The quality of the medical data and the quality and extent to which the income and expenditure was correctly allocated to the patient's stay are key elements in analysing each case. The methodology of this study is centred on the quality of the data retrieval. The casemix group is one of the decisive variables in matching stays. The quality of this information is essential in order to ensure the quality of the analysis of the income and expenditure by stay. The encoded medical data (diagnostics and CCAM procedures) were checked for all 254 stays by referring to the medical file and hospitalisation report before matching up the stays. All hospitalisation incomes were allocated to the stay concerned. Stay expenditure incurred was broken down into the main expenditure items of medication, MID, and medical-technical procedures performed. In total, 50% of expenditure were directly allocated to stays, including 100% of expenditure on medical-technical procedures carried out. Of the medical costs, only expenditure for nonimplantable medical devices (and therefore not reimbursed over and above the DRG) were not allocated directly to stays. The consumption of medical devices is nonetheless higher for treatment of emergency ACS cases (angioplasty balloon, thromboaspiration catheter). This can reduce the actual cost for medical devices of emergency admissions and reduce the actual expenditure difference between scheduled and emergency stays.
Few studies have been carried out on the financial impact of nonscheduled patient treatment [4, 8, 9] . A study conducted on complete hospitalisation data in 2003 and sent as part of the ENC by the University Hospitals of Strasbourg showed that stays identified as nonscheduled entailed on average an additional cost of 63% compared with scheduled hospital stays [4] . Nonscheduled stays in the serious cardiovascular events category appear to be less costly than scheduled stays. However, the information on whether the stay was scheduled or an emergency was not routinely available and was encoded later for all stays, which is one of the limits of the study. In our study, nonscheduled hospitalisation for treatment of an ACS represented an additional average cost of 30.4% compared to scheduled hospitalisation. An Australian study [9] demonstrated that there was a significant difference between the costs of emergency and scheduled admissions for surgery on an aneurism of the abdominal aorta. An American study [10] showed for nine surgical DRG, that emergency admissions usually entail higher hospitalisation costs.
Medical economic studies carried out in cardiology were geared towards ''cost-benefit'' analyses or ''costeffectiveness'' of using new molecules or new invasive techniques [11] . A French study assessed the cost of hospital treatment of cardiovascular events using data from the PMSI [12] . The cost observed for coronary angioplasty using stent was less than in our study, ranging from 5750 D in the private sector to 5178 D in the public sector. Two other studies analysed the cost of treating acute myocardial infarction using the English-speaking equivalent--APR-DRG--of the French PMSI classification [13, 14] . For one of these studies [13] , the average cost of treating the infarction was between 5261 D ± 2768 D and 7527 D ± 4614 D . The standard deviations recorded reveal a high level of variability in costs per stay. The second study [12] showed an increase in the cost of resources used depending on the severity of the APR-DRG, which was also shown in our study. Nonetheless, the comparison with the data from our study remains limited since the APR-DRG classification algorithm cannot be strictly compared with the algorithm applied in the French PMSI model. The results of the ENC for the 2005 data showed average costs by case-mix group similar to those recorded in our study. The average gross cost without removing extreme values observed on the 2005 ENC is 6350.70 D for the 05K05V case-mix group, 9303.30 D for the 05K05W case-mix group, 5005.40 D for the 05K06V case-mix group and 7840.30 D days for the 05K06W case-mix group. Only the cost recorded for the 05K05V case-mix group is significantly higher than the one recorded in our study.
Limitations of the study
The financial evaluation obtained for each stay and the cost incurred for the treatment of an ACS vary according to the type of procedure (medical treatment alone or cardiac surgery) and the seriousness of the condition of the patient requiring in some situations for the patient to be transferred to a reanimation or surgical unit. The study of the additional cost of nonscheduled treatment requires certain factors to be excluded such as variability of costs and income, in order to compare the stays according to the ''scheduled/nonscheduled'' variable alone. This led us to opt for treatment of ACS requiring coronary stenting, as this activity is carried out in coronarography at the same time for both scheduled and emergency cases. Due to this methodological choice, the results observed in our study cannot be extrapolated to include all emergency ACS cases, because 30% of ACS cases lead to medical procedures alone without coronary revascularisation. Finally, we did not assess the financial impact of the initial seriousness of the clinical conditions of the patients, estimated using a risk score upon admission.
Conclusion
The description of our population complies with the recommendations of good practice; the majority of urgent procedures were primary angioplasties of ACS with raised ST segmentation and ACS without raised ST segmentation with comorbidities or complications. However, the financial value proposed for both of these DRG groups shows that it brings about the lowest level of positive differences between income and expenditure and the highest negative differences. The application of the recommendations of learned societies on emergency procedures using angioplasty with stent for ACS, especially outside of normal working hours, involves a financial investment by the hospitals, as the costs are only partially covered by income from the DRG or the USIC. With the current method of remuneration, scheduled coronary stent implants provide on the contrary the highest financial benefits, especially in the ACS without raised ST segmentation group without complication. Continuing with this method of remuneration (T2A) could in the long term have a harmful impact on the financial capacities of our hospitals to treat cases of ACS in accordance with guidelines. In order to achieve the best compromise between the health of our patients who have suffered from an ACS and the financial health of our hospitals, it is necessary to allocate specific additional funds to hospitals offering specific emergency treatment, and the medical profession must be able to respect the indications for catheterization that may be carried out as a scheduled procedure.
